4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-15-006808
Director acquired 4,884,755 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Canaan IX L.P. Director | 2015-10-14 | Conversion | +4,884,755 | 4,884,755 | I: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Canaan IX L.P. Director | 2015-10-14 | Conversion · Series B-1 Redeemable Convertible Preferred Stock | −3,566,337 | 0 | I: show line 2 in the form | |||||
| Canaan IX L.P. Director | 2015-10-14 | Conversion · Series C Redeemable Convertible Preferred Stock | −1,318,418 | 0 | I: show line 3 in the form |
Loading xslF345X03/doc4.xml…